[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,064,793
  • Shares Outstanding, K 218,960
  • Annual Sales, $ 51,950 K
  • Annual Income, $ -265,940 K
  • EBIT $ -299 M
  • EBITDA $ -295 M
  • 60-Month Beta 0.89
  • Price/Sales 40.63
  • Price/Cash Flow N/A
  • Price/Book 3.55

Options Overview Details

View History
  • Implied Volatility 90.64% (+1.91%)
  • Historical Volatility 59.57%
  • IV Percentile 52%
  • IV Rank 14.07%
  • IV High 363.10% on 02/13/26
  • IV Low 46.01% on 08/22/25
  • Expected Move (DTE 4) 0.41 (4.33%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 7,722
  • Volume Avg (30-Day) 2,241
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 63,159
  • Open Int (30-Day) 50,640
  • Expected Range 9.02 to 9.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.40
  • Number of Estimates 5
  • High Estimate $-0.36
  • Low Estimate $-0.42
  • Prior Year $-0.39
  • Growth Rate Est. (year over year) -2.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.86 +19.97%
on 05/21/26
10.39 -9.24%
on 06/18/26
+1.05 (+12.53%)
since 05/18/26
3-Month
7.38 +27.78%
on 03/30/26
10.39 -9.24%
on 06/18/26
+0.94 (+11.07%)
since 03/18/26
52-Week
6.23 +51.36%
on 02/17/26
16.44 -42.64%
on 12/08/25
+1.10 (+13.21%)
since 06/18/25

Most Recent Stories

More News
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

MDLZ : 60.12 (-1.22%)
NU : 12.71 (-1.40%)
RMD : 188.63 (+1.26%)
SONO : 14.68 (+2.73%)
OCUL : 9.43 (-2.18%)
Why Ocular Therapeutix (OCUL) Stock Is Up Today

Why Ocular Therapeutix (OCUL) Stock Is Up Today

OCUL : 9.43 (-2.18%)
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-R safety data Ocular to conduct interim SOL-R safety analysis in 4Q 2026 to reach...

OCUL : 9.43 (-2.18%)
3 of Wall Street’s Favorite Stocks That Concern Us

3 of Wall Street’s Favorite Stocks That Concern Us

WH : 84.20 (+0.75%)
LOW : 222.20 (+2.27%)
OCUL : 9.43 (-2.18%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 9.43 (-2.18%)
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

BEDFORD, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced...

OCUL : 9.43 (-2.18%)
Ocular Therapeutix™ to Host Investor Day on June 17, 2026

In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD  Company...

OCUL : 9.43 (-2.18%)
1 Russell 2000 Stock to Research Further and 2 Facing Headwinds

1 Russell 2000 Stock to Research Further and 2 Facing Headwinds

PJT : 155.47 (+0.30%)
PUMP : 14.75 (-0.74%)
OCUL : 9.43 (-2.18%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., May 15, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 9.43 (-2.18%)
3 Stocks Under $10 That Fall Short

3 Stocks Under $10 That Fall Short

LCID : 5.36 (+4.28%)
SWIM : 5.82 (+3.56%)
OCUL : 9.43 (-2.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 11.11
2nd Resistance Point 10.75
1st Resistance Point 10.09
Last Price 9.43
1st Support Level 9.07
2nd Support Level 8.71
3rd Support Level 8.05

See More

52-Week High 16.44
Fibonacci 61.8% 12.54
Fibonacci 50% 11.34
Fibonacci 38.2% 10.13
Last Price 9.43
52-Week Low 6.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.